lenalidomide,rituximab,acalabrutinib
astrazeneca
['lenalidomide', 'ritux', 'acalabrutinib', 'imab ']
#ash22 chemotherapy-free triplet regimen of #acalabrutinib, #lenalidomide, and #rituximab (alr) yields high rates of mrd-negative complete remission when used as a frontline treatment in patients with #mcl 
A magazine from @ASH_Hematology offering news and views for the broader hematology/oncology community.